- Home
- Products
- Customized ADCs
- CR2
- Anti-CR2 (THB-5)-MCC-DM1 ADC
Anti-CR2 (THB-5)-MCC-DM1 ADC (CAT#: ADC-W-622)
This ADC product is comprised of an anti-CR2 monoclonal antibody (THB-5) conjugated via a MCC linker to DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- CR2
- Alternative Names
- CR2; complement component (3d/Epstein Barr virus) receptor 2; CR; C3DR; CD21; CVID7; SLEB9; complement receptor type 2; EBV receptor; complement C3d receptor;
- Target Entrez Gene ID
- 1380
- Target UniProt ID
- P20023
- Overview
- This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
- Overview
- Anti-CR2 IgG2a Antibody, THB-5
- Generic name
- THB-5
- Species Reactivity
- Mouse
- Name
- MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine)
- Description
- Derived from Maytansinoid,a group of cytotoxins structurally similar to rifamycin, geldanamycin, and ansatrienin. The eponymous natural cytotoxic agent maytansine is a 19-member lactam (ansa
macrolide) structure originally isolated from the Ethiopian shrub Maytenus ovatus. Maytansinoids can bind to tubulin at or near the vinblastine-binding site, which interfere the formation of microtubules and depolymerize already formed microtubules, inducing mitotic arrest in the intoxicated cells.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-PVRL4 (Enfortumab vedotin)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-2400)
- Anti-APP (Gantenerumab)-MC-Vc-PAB-SN38 ADC (CAT#: ADC-W-684)
- Anti-MS4A1 (Ibritumomab)-SPDB-DM4 ADC (CAT#: ADC-W-1551)
- Anti-CA9-VC-MMAE ADC (CAT#: ADC-W-475)
- Anti-ROR1 (clone R11) scFv-Fc-Sec ADC (CAT#: ADC-W-434)
- Anti-MET (Emibetuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2375)
- Anti-IL20 (Fletikumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2405)
- Anti-TNF (Nerelimomab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1859)
- Anti-S1P (Sonepcizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2437)
- Anti-TNFRSF8 (cAC10)-Mc-VC-MMAE ADC (CAT#: ADC-W-343)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-622. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
CAT# | Product Name | Linker | Payload |
ADC-W-621 | Anti-CR2 (THB-5)-SPP-DM1 ADC | SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-624 | Anti-CR2 (THB-5)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
ADC-W-623 | Anti-CR2 (THB-5)-Mc-VC-PABC-MMAE ADC | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
ADC-W-330 | Anti-CR2 (clone HB135)-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
CAT# | Product Name | Linker | Payload |
ADC-W-534 | Anti-ITGAE (clone M290)-MCC-DM1 ADC | Mcc (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-626 | Anti-CD22 (10F4v3)-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-511 | Anti-ERBB2 (cFRP5)-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-618 | Anti-MS4A1-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-050 | Protein G-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
CAT# | Product Name | Linker | Payload |
ADC-AA-054 | Protein A-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-050 | Protein G-MCC-DM1 ADC | MCC (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-008 | anti-HIgG(Fc)-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-AA-015 | anti-HIgG(Fc)Fab-N-DM1 ADC | Noncleavable linkers | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
ADC-W-541 | Anti-CD44 (clone BIWA 4)-DM1 ADC | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.